Event Overview:

The Society of Urologic Oncology will sponsor this highly interactive meeting where all attendees participate in the discussions led by internationally renowned urologic oncologists, medical oncologists and scientists. State-of-the-art translational topics on prostate, kidney and bladder cancer, as well as strategies in urologic oncology will be discussed. 

Attendee Participation
This meeting is designed to be a discussion of issues among members of the urologic oncology community. All attendees participate in the discussions and are encouraged to interact with program faculty.

Exhibitor Information:

The expected 550 attendees want to meet you face-to-face and examine your products first-hand. By exhibiting at the meeting, your company will be listed in promotional materials and the program book. Space is limited, so act quickly!

About SUO:

The Society of Urologic Oncology (SUO) was created in 1984 to enable qualified members primarily interested in the care of patients with malignant genitourinary diseases to meet for the purpose of discussion, development, and implementation of ideas to improve care. The Society and its bylaws conform to the guidelines and bylaws of the American Urological Association (AUA).

The purpose of the SUO is to develop educational and research initiatives and to study issues in urologic oncology and provide physician statements that represent a state of the art assessment of these issues to other organizations.